Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 1, p. 1, doi. 10.1111/tid.13449
- By:
- Publication type:
- Article